Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meina Liang

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
ACS Pharmacology & Translational Science|May 15, 2025
Investigations of Enteric-Coated Tablet Propyl Gallate-Induced Nephrotoxicity in Beagles as well as Human and Dog Renal Proximal Tubule Epithelial CellsSi Mou, B Timothy Hummer, Jiaqi Yuan, et al.
Journal of Clinical Pharmacology|September 28, 2011
Mechanistic modeling of antigen sink effect for mavrilimumab following intravenous administration in patients with rheumatoid arthritisBing Wang, Yvonne Y Lau, Meina Liang, et al.
Antibodies (Basel, Switzerland)|September 24, 2019
Multiplex LC-MS/MS Assays for Clinical Bioanalysis of MEDI4276, an Antibody-Drug Conjugate of Tubulysin Analogue Attached via Cleavable Linker to a Biparatopic Humanized Antibody against HER-2Morse Faria, Marlking Peay, Brandon Lam, et al.
Quantitative Imaging in Medicine and Surgery|November 10, 2025
Automated segmentation of the primary tumor in nasopharyngeal carcinoma using a deep learning framework in positron emission tomography imaging: a comparative studyMeina Liang, Chengmao Guo, Haiwen Li, et al.
Cytometry. Part B, Clinical Cytometry|September 20, 2015
Evaluation of assay interference and interpretation of CXCR4 receptor occupancy results in a preclinical study with MEDI3185, a fully human antibody to CXCR4Martin Schwickart, Carlos Chavez, Simon Henderson, et al.
Journal of Immunological Methods|July 3, 2020
A new method for identification of outliers in immunogenicity assay cut point dataJianchun Zhang, Rosalin Hgp Arends, Robert J Kubiak, et al.
The AAPS Journal|November 8, 2017
Recommendations for the Assessment and Management of Pre-existing Drug-Reactive Antibodies During Biotherapeutic DevelopmentLi Xue, Adrienne Clements-Egan, Lakshmi Amaravadi, et al.
The AAPS Journal|January 30, 2016
Pre-existing Antibody: Biotherapeutic Modality-Based ReviewBoris Gorovits, Adrienne Clements-Egan, Mary Birchler, et al.
Pathogens & Immunity|March 1, 2019
HBV and HIV/HBV Infected Patients Have Distinct Immune Exhaustion and Apoptotic Serum Biomarker ProfilesMohamed Tarek M Shata, Enass A Abdel-Hameed, Susan D Rouster, et al.
Analytical Chemistry|October 11, 2024
Extensive Biotransformation Profiling of AZD8205, an Anti-B7-H4 Antibody-Drug Conjugate, Elucidates Pathways Underlying Its Stability <i>In Vivo</i>Yue Huang, Hui Yin Tan, Jiaqi Yuan, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
ACS Pharmacology & Translational Science|May 15, 2025
Investigations of Enteric-Coated Tablet Propyl Gallate-Induced Nephrotoxicity in Beagles as well as Human and Dog Renal Proximal Tubule Epithelial CellsSi Mou, B Timothy Hummer, Jiaqi Yuan, et al.
Journal of Clinical Pharmacology|September 28, 2011
Mechanistic modeling of antigen sink effect for mavrilimumab following intravenous administration in patients with rheumatoid arthritisBing Wang, Yvonne Y Lau, Meina Liang, et al.
Antibodies (Basel, Switzerland)|September 24, 2019
Multiplex LC-MS/MS Assays for Clinical Bioanalysis of MEDI4276, an Antibody-Drug Conjugate of Tubulysin Analogue Attached via Cleavable Linker to a Biparatopic Humanized Antibody against HER-2Morse Faria, Marlking Peay, Brandon Lam, et al.
Quantitative Imaging in Medicine and Surgery|November 10, 2025
Automated segmentation of the primary tumor in nasopharyngeal carcinoma using a deep learning framework in positron emission tomography imaging: a comparative studyMeina Liang, Chengmao Guo, Haiwen Li, et al.
Cytometry. Part B, Clinical Cytometry|September 20, 2015
Evaluation of assay interference and interpretation of CXCR4 receptor occupancy results in a preclinical study with MEDI3185, a fully human antibody to CXCR4Martin Schwickart, Carlos Chavez, Simon Henderson, et al.
Journal of Immunological Methods|July 3, 2020
A new method for identification of outliers in immunogenicity assay cut point dataJianchun Zhang, Rosalin Hgp Arends, Robert J Kubiak, et al.
The AAPS Journal|November 8, 2017
Recommendations for the Assessment and Management of Pre-existing Drug-Reactive Antibodies During Biotherapeutic DevelopmentLi Xue, Adrienne Clements-Egan, Lakshmi Amaravadi, et al.
The AAPS Journal|January 30, 2016
Pre-existing Antibody: Biotherapeutic Modality-Based ReviewBoris Gorovits, Adrienne Clements-Egan, Mary Birchler, et al.
Pathogens & Immunity|March 1, 2019
HBV and HIV/HBV Infected Patients Have Distinct Immune Exhaustion and Apoptotic Serum Biomarker ProfilesMohamed Tarek M Shata, Enass A Abdel-Hameed, Susan D Rouster, et al.
Analytical Chemistry|October 11, 2024
Extensive Biotransformation Profiling of AZD8205, an Anti-B7-H4 Antibody-Drug Conjugate, Elucidates Pathways Underlying Its Stability <i>In Vivo</i>Yue Huang, Hui Yin Tan, Jiaqi Yuan, et al.
Pageof 8